A new topical medication based on a mixture of triterpenes found in birch trees has been FDA-approved for the care of patients with Epidermolysis Bullosa, a rare skin disease.
It was brought to my attention by a fellow botanical expert (thanks Steven!!) that this is not the 3rd, but rather the 4th drug approved by this FDA pathway for botanical drugs (NexoBrid approved in 2022 for burn debridement). I've corrected the text above and will cover this other drug soon!
It was brought to my attention by a fellow botanical expert (thanks Steven!!) that this is not the 3rd, but rather the 4th drug approved by this FDA pathway for botanical drugs (NexoBrid approved in 2022 for burn debridement). I've corrected the text above and will cover this other drug soon!
This is very encouraging news!
yes, indeed!